Literature DB >> 25342326

MicroRNA library-based functional screening identified miR-137 as a suppresser of gastric cancer cell proliferation.

Xiushan Zheng1, Jiaqiang Dong, Taiqian Gong, Zhiyong Zhang, Ying Wang, Yunming Li, Yulong Shang, Kai Li, Gui Ren, Bin Feng, Juntang Li, Qifei Tian, Shanhong Tang, Li Sun, Mengbin Li, Hongwei Zhang, Daiming Fan.   

Abstract

PURPOSES: Uncontrolled proliferation is a key characteristic of gastric carcinogenesis and the precise mechanisms underlying the altered proliferation behaviors of GC cells have not been clearly elucidated. miRNAs has been suggested to play a crucial role in the pathogenesis and development of various cancers. In the present study, we employed an impedance-based real-time cell electronic sensing (RT-CES) system to detect the effects of ectopically expressed miRNAs on GC cell proliferation.
METHODS: miRNA mimics were transfected into gastric cancer cell line SGC7901 and the effect of individual miRNA on the proliferation rate of the cells was measured by the RT-CES system. The screening results were validated with qRT-PCR and miR-137 was selected for further research. The effects of ectopically expressed miR-137 on GC cell growth and cell cycle progress were measured using MTT assay and flow cytometry. The target gene of miR-137 was predicted using different bioinformatics tools and the direct interaction between miR-137 and the 3'-UTR was confirmed with a luciferase reporter assay. The in vivo effect of miR-137 on GC cell proliferation was examined with a tumor-bearing nude mouse model. The correlation between miR-137 expression and patients' prognosis was explored in a cohort of 38 patients. Prognosis was explored in a cohort of 38 patients.
RESULTS: Ectopic expression of miR-137 was sufficient to inhibit GC cell proliferation both in vitro and in vivo. Bioinformatics prediction and luciferase reporter assay revealed CDK6 as a target gene through which miR-137 exerted an inhibitory function. Moreover, miR-137 expression positively correlated with better prognosis.
CONCLUSION: Our data indicated an important regulatory role of miR-137 in GC cell proliferation and that it may be explored as a prognostic marker for GC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25342326     DOI: 10.1007/s00432-014-1847-4

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  31 in total

1.  miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells.

Authors:  Ming Liu; Nan Lang; Meng Qiu; Feng Xu; Qiu Li; Qiulin Tang; Ji Chen; Xi Chen; Siyuan Zhang; Zhen Liu; Jitao Zhou; Yajie Zhu; Yu Deng; Yi Zheng; Feng Bi
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

Review 2.  Significance of cell proliferation measurement in gastric cancer.

Authors:  D L Schipper; M J Wagenmans; W H Peters; D J Wagener
Journal:  Eur J Cancer       Date:  1998-05       Impact factor: 9.162

3.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

4.  MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab.

Authors:  Naohiro Nishida; Koshi Mimori; Muller Fabbri; Takehiko Yokobori; Tomoya Sudo; Fumiaki Tanaka; Kohei Shibata; Hideshi Ishii; Yuichiro Doki; Masaki Mori
Journal:  Clin Cancer Res       Date:  2011-01-10       Impact factor: 12.531

5.  miR-107 targets cyclin-dependent kinase 6 expression, induces cell cycle G1 arrest and inhibits invasion in gastric cancer cells.

Authors:  Li Feng; Yun Xie; Hao Zhang; Yunlin Wu
Journal:  Med Oncol       Date:  2011-01-25       Impact factor: 3.064

6.  miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1.

Authors:  Jintang Xia; Zhiqiang Wu; Chunping Yu; Weiling He; Haiqing Zheng; Yulong He; Weihua Jian; Lianzhou Chen; Luanjing Zhang; Wen Li
Journal:  J Pathol       Date:  2012-05-23       Impact factor: 7.996

7.  miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma.

Authors:  Cheng-Kui Cai; Guang-Yi Zhao; Li-Ying Tian; Lie Liu; Kang Yan; Yun-Lei Ma; Zhen-Wei Ji; Xiao-Xiang Li; Kang Han; Jie Gao; Xiu-Chun Qiu; Qing-Yu Fan; Tong-Tao Yang; Bao-An Ma
Journal:  Oncol Rep       Date:  2012-08-24       Impact factor: 3.906

8.  miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1.

Authors:  Xiaolan Zhu; Yuefeng Li; Huiling Shen; Hao Li; Lulu Long; Lulu Hui; Wenlin Xu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2012-11-23       Impact factor: 3.848

9.  MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.

Authors:  Qingbo Lang; Changquan Ling
Journal:  Biochem Biophys Res Commun       Date:  2012-08-23       Impact factor: 3.575

10.  Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo.

Authors:  Yantao Du; Zhaojun Liu; Liankun Gu; Jing Zhou; Bu-dong Zhu; Jiafu Ji; Dajun Deng
Journal:  BMC Cancer       Date:  2012-06-15       Impact factor: 4.430

View more
  13 in total

1.  MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8.

Authors:  Ying Wang; Po Xu; Jun Yao; Ruina Yang; Zhenguo Shi; Xiaojuan Zhu; Xiaoshan Feng; Shegan Gao
Journal:  Target Oncol       Date:  2016-04       Impact factor: 4.493

2.  microRNA-137 is downregulated in thyroid cancer and inhibits proliferation and invasion by targeting EGFR.

Authors:  Yingwei Luo; Xi Li; Jianwei Dong; Weifeng Sun
Journal:  Tumour Biol       Date:  2015-12-22

3.  MicroRNA-126 affects ovarian cancer cell differentiation and invasion by modulating expression of vascular endothelial growth factor.

Authors:  Jianqiao Luo; Caidan Zhu; Hongya Wang; Li Yu; Jianwei Zhou
Journal:  Oncol Lett       Date:  2018-02-12       Impact factor: 2.967

4.  miR-137 plays tumor suppressor roles in gastric cancer cell lines by targeting KLF12 and MYO1C.

Authors:  Yantao Du; Yichen Chen; Furong Wang; Liankun Gu
Journal:  Tumour Biol       Date:  2016-07-28

5.  Chaperone-mediated autophagy regulates proliferation by targeting RND3 in gastric cancer.

Authors:  Jinfeng Zhou; Jianjun Yang; Xing Fan; Sijun Hu; Fenli Zhou; Jiaqiang Dong; Song Zhang; Yulong Shang; Xiaoming Jiang; Hao Guo; Ning Chen; Xiao Xiao; Jianqiu Sheng; Kaichun Wu; Yongzhan Nie; Daiming Fan
Journal:  Autophagy       Date:  2016       Impact factor: 16.016

6.  Induction of miR-137 by Isorhapontigenin (ISO) Directly Targets Sp1 Protein Translation and Mediates Its Anticancer Activity Both In Vitro and In Vivo.

Authors:  Xingruo Zeng; Zhou Xu; Jiayan Gu; Haishan Huang; Guangxun Gao; Xiaoru Zhang; Jingxia Li; Honglei Jin; Guosong Jiang; Hong Sun; Chuanshu Huang
Journal:  Mol Cancer Ther       Date:  2016-02-01       Impact factor: 6.261

Review 7.  Dysregulation of non-coding RNAs in gastric cancer.

Authors:  Qing Yang; Ren-Wen Zhang; Peng-Cheng Sui; Hai-Tao He; Lei Ding
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

8.  Clinical Significance of MiR-137 Expression in Patients with Gastric Cancer After Radical Gastrectomy.

Authors:  Qiaoyan Gu; Jun Zhang; Haifeng Hu; Yu-E Tan; Shengmei Shi; Yuanyuan Nian
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

9.  Low Expression of Mir-137 Predicts Poor Prognosis in Cutaneous Melanoma Patients.

Authors:  Nan Li
Journal:  Med Sci Monit       Date:  2016-01-14

10.  Prognostic value of microRNAs in gastric cancer: a meta-analysis.

Authors:  Yue Zhang; Dong-Hui Guan; Rong-Xiu Bi; Jin Xie; Chuan-Hua Yang; Yue-Hua Jiang
Journal:  Oncotarget       Date:  2017-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.